Search research articles
Contact Us
Filters
Showing results (191-200 of 319) with videos related to
Page
of 32
Sort By:
Urologic Oncology
|
October 7, 2004
A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
Donald S Kaufman, Michael A Carducci, Tim M Kuzel, et al.
BMC Anesthesiology
|
October 18, 2024
Startle sign events induced by mechanical manipulation during surgery for neuroma localization: a retrospective cohort study
Jonathan M Gorky, Sarah J Karinja, Sylvia L Ranjeva, et al.
BJU International
|
September 24, 2010
A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database
Howard S Kim, Daniel M Moreira, Matthew R Smith, et al.
BJU International
|
March 30, 2010
The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer
Matthew S Katz, Jason A Efstathiou, Anthony V D'Amico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Allan Lipton, Matthew R Smith, Karim Fizazi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 12, 2026
Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial
Bertrand Tombal, Maha Hussain, Fred Saad, et al.
Journal of Applied Clinical Medical Physics
|
May 26, 2026
Evaluation of a super-resolution deep learning reconstruction algorithm in abdominal CT imaging-A qualitative and quantitative performance analysis
Aria M Salyapongse, Martin G Wagner, Meghan G Lubner, et al.
The Journal of Urology
|
July 8, 2015
Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer
Matthew R Smith, Dana E Rathkopf, Peter F A Mulders, et al.
CA: a Cancer Journal for Clinicians
|
February 4, 2010
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology
Glenn N Levine, Anthony V D'Amico, Peter Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2015
Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate-Treated Castration-Resistant Prostate Cancer Patients
Xu S Xu, Charles J Ryan, Kim Stuyckens, et al.
Page
of 32
Search research articles
Search
Showing results (191-200 of 319) with videos related to
Sort By:
Page
of 32
Urologic Oncology
|
October 7, 2004
A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
Donald S Kaufman, Michael A Carducci, Tim M Kuzel, et al.
BMC Anesthesiology
|
October 18, 2024
Startle sign events induced by mechanical manipulation during surgery for neuroma localization: a retrospective cohort study
Jonathan M Gorky, Sarah J Karinja, Sylvia L Ranjeva, et al.
BJU International
|
September 24, 2010
A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database
Howard S Kim, Daniel M Moreira, Matthew R Smith, et al.
BJU International
|
March 30, 2010
The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer
Matthew S Katz, Jason A Efstathiou, Anthony V D'Amico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Allan Lipton, Matthew R Smith, Karim Fizazi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 12, 2026
Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial
Bertrand Tombal, Maha Hussain, Fred Saad, et al.
Journal of Applied Clinical Medical Physics
|
May 26, 2026
Evaluation of a super-resolution deep learning reconstruction algorithm in abdominal CT imaging-A qualitative and quantitative performance analysis
Aria M Salyapongse, Martin G Wagner, Meghan G Lubner, et al.
The Journal of Urology
|
July 8, 2015
Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer
Matthew R Smith, Dana E Rathkopf, Peter F A Mulders, et al.
CA: a Cancer Journal for Clinicians
|
February 4, 2010
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology
Glenn N Levine, Anthony V D'Amico, Peter Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2015
Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate-Treated Castration-Resistant Prostate Cancer Patients
Xu S Xu, Charles J Ryan, Kim Stuyckens, et al.
Page
of 32